PALLESCHI, MICHELA

PALLESCHI, MICHELA  

Dottorandi  

Mostra records
Risultati 1 - 20 di 33 (tempo di esecuzione: 0.034 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET A. Gennari, E. Brain, A. De Censi, O. Nanni, R. Wuerstlein, A. Frassoldati, J. Cortes, V. Rossi, ...M. Palleschi, J.L. Alberini, F. Matteucci, A. Piccardo, G. Sacchetti, H. Ilhan, F. D’Avanzo, B. Ruffilli, S. Nardin, M. Monti, M. Puntoni, V. Fontana, L. Boni, N. Harbeck, 9999-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study Botticelli A, Caputo R, Scagnoli S, Pisegna S, De Laurentiis M, Curigliano G, Lambertini M, Panta...no F, Palazzo A, Paris I, Vernieri C, Tedesco B, Giampaglia M, Palleschi M, Ballatore Z, Alesini D, D'Auria G, Fabbri A, Rossi L, Verrazzo A, Scafetta R, Marinelli D, Sposetti C, Barberi V, Strigari L, Marchetti P, Santini D, Fabi A. 9999-01-01 THE ONCOLOGIST - 1.01 Articolo in rivista -
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy Roberta Maltoni; Andrea Roncadori; William Balzi; Massimiliano Mazza; Fabio Nicolini; Michela Pal...leschi; Paola Ulivi; Sara Bravaccini 2024-01-01 BIOMEDICINES - 1.01 Articolo in rivista biomedicines-12-00498-v2.pdf
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial. Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M..., Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG). 2023-01-01 JAMA ONCOLOGY - 1.01 Articolo in rivista -
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology Merloni F.; Palleschi M.; Gianni C.; Casadei C.; Curcio A.; Romeo A.; Rocchi M.; Cima S.; Sirico ...M.; Sarti S.; Cecconetto L.; Mariotti M.; Di Menna G.; De Giorgi U. 2023-01-01 FRONTIERS IN ONCOLOGY - 1.01 Articolo in rivista Merloni_2023.pdf
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives Sirico, Marianna; Virga, Alessandra; Conte, Benedetta; Urbini, Milena; Ulivi, Paola; Gianni, Cate...rina; Merloni, Filippo; Palleschi, Michela; Gasperoni, Marco; Curcio, Annalisa; Saha, Debjani; Buono, Giuseppe; Muñoz, Montserrat; De Giorgi, Ugo; Schettini, Francesco 2023-01-01 CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - 1.01 Articolo in rivista Sirico_Neoadjuvant endocrine therapy for luminal breast tumors_2023_january.pdf
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure Merloni, Filippo; Palleschi, Michela; Casadei, Chiara; Romeo, Antonino; Curcio, Annalisa; Casadei..., Roberto; Stella, Franco; Ercolani, Giorgio; Gianni, Caterina; Sirico, Marianna; Cima, Simona; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; De Giorgi, Ugo 2023-01-01 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - 1.01 Articolo in rivista 2023-Merloni (Ther Adv Med Oncol)- Oligometastatic breast cancer REVIEW.pdf
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer Gianni C.; Palleschi M.; Merloni F.; Bleve S.; Casadei C.; Sirico M.; Di Menna G.; Sarti S.; Cecc...onetto L.; Mariotti M.; De Giorgi U. 2023-01-01 CANCERS - 1.01 Articolo in rivista Potential Impact of Preoperative Circulating Biomarkers.pdf
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study Pisegna, S.; Scagnoli, S.; Toss, A.; Caputo, R.; De Laurentiis, M.; Palleschi, M.; De Giorgi, U.;... Cortesi, E.; Fabbri, M.A.; Fabi, A.; Paris, I.; Orlandi, A.; Curigliano, G.; Criscitiello, C.; Garrone, O.; Tomasello, G.; D{'}Auria, G.; Vici, P.; Ricevuto, E.; Domati, F.; Piombino, C.; Parola, S.; Scafetta, R.; Cirillo, A.; Salimbeni, B.T.; Di Lisa, F.S.; Strigari, L.; Preissner, R.; Simmaco, M.; Santini, D.; Marchetti, P.; Botticelli, A. 2023-01-01 ANNALS OF ONCOLOGY - 1.06 Abstract in rivista -
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer Schepisi G.; Gianni C.; Palleschi M.; Bleve S.; Casadei C.; Lolli C.; Ridolfi L.; Martinelli G.; ...De Giorgi U. 2023-01-01 CANCERS - 1.01 Articolo in rivista -
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna;... Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo 2022-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista graphic.pdfijms-23-14197.pdf
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecc...onetto L.; Di Menna G.; Schettini F.; De Giorgi U. 2022-01-01 FRONTIERS IN ONCOLOGY - 1.01 Articolo in rivista -
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; ...Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A. 2022-01-01 SCIENTIFIC REPORTS - 1.01 Articolo in rivista -
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinell...i G.; Fabbri F.; Gallerani G. 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-03925-v2.pdfcancers-14-03925-s001.zip
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.;... Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R. 2022-01-01 ESMO OPEN - 1.04 Replica / breve intervento (e simili) -
Body mass index (BMI) and benefit from adjuvant chemotherapy in breast cancer: is it enough? Palleschi M.; Scarpi E.; Casadei C. 2021-01-01 BREAST CANCER RESEARCH AND TREATMENT - 1.01 Articolo in rivista -
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.;... Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R. 2021-01-01 ESMO OPEN - 1.01 Articolo in rivista -
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trial Fabi A, Terrenato I, Vidiri A, Villani V, Tanzilli A, Airoldi M, Pedani F, Magri V, Palleschi M, ...Donadio M, Catania G, Nisticò C, Carapella C, Rudà R, Pace A, Maschio M, Telera S, Cognetti F; 2021-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Germline BRCA-mutated metastatic breast cancer with positive hormone receptor Palleschi M.; Iaia M.L.; Casadei C. 2021-01-01 BREAST CANCER RESEARCH AND TREATMENT - 1.04 Replica / breve intervento (e simili) -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) Vernieri C.; Nichetti F.; Lalli L.; Moscetti L.; Giorgi C.A.; Griguolo G.; Marra A.; Randon G.; R...ea C.G.; Ligorio F.; Scagnoli S.; De Angelis C.; Molinelli C.; Fabbri A.; Ferraro E.; Trapani D.; Milani A.; Agostinetto E.; Bernocchi O.; Catania G.; Vantaggiato A.; Palleschi M.; Moretti A.; Basile D.; Cinausero M.; Ajazi A.; Castagnoli L.; Vullo S.L.; Gerratana L.; Puglisi F.; La Verde N.; Arpino G.; Rocca A.; Ciccarese M.; Pedersini R.; Fabi A.; Generali D.; Losurdo A.; Montemurro F.; Curigliano G.; Del Mastro L.; Michelotti A.; Cortesi E.; Guarneri V.; Pruneri G.; Mariani L.; De Braud F. 2021-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -